Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Win, N. Screaton, I. Kayani, M. Shastry, R. Endozo, R. Shortman, B. Hutton, P. Ell, A. Groves (Stevenage, Cambridge, United Kingdom). Changes in pulmonary ¹⁸F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study. Eur Respir J 2010; 36: Suppl. 54, 818

Member's Comments

No comment yet.

Related content which might interest you: MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension. Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020 Year: 2021 Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 HRCT in the diagnosis of diffuse lung disease - overlap issues Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 18F-FDG-PET/CT appearances in pulmonary fibrosis; initial experience Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008 Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018 Year: 2018 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 The role of computed tomography in differential diagnosis of pulmonary TB in patients with chronic renal failure in the terminal stage. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021 Year: 2022 Lung cancer in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 1216-1219 Year: 2001